FDA Asks Whether User Fees Will Repair OTC Monograph Process

FDA schedules a public meeting June 10 and opens a docket for stakeholder input on the potential development of a user fee program for OTC monograph drugs. CDER points out the OTC monograph is "one of the largest and most complex regulatory programs ever undertaken at FDA."

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America